MedTrace Logo

Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets

NCT04199624 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-09-22

No results posted yet for this study

Summary

This study evaluates the use of ascorbic acid, vitamin C, to temporary reduce gastric pH in individuals with omeprazole induced hypochlorhydria. All participants will receive ascorbic acid tablets to measure the change in gastric pH.

Conditions

  • Hypochlorhydria

Interventions

DRUG

Omeprazole 20mg

Omeprazole twice daily x 5 days

DIETARY_SUPPLEMENT

Vitamin C

Ascorbic acid x 1 on day 5

Sponsors & Collaborators

  • Hala Fadda

    collaborator UNKNOWN

  • Butler University

    collaborator UNKNOWN

  • Indiana University

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2023-06-07
Completion
2023-06-07
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04199624 on ClinicalTrials.gov